Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mitologics

Mitologics
2009 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of biotechnological research services intended to detect mitochondrial injury. The company's services are primarily focused on predictive toxicology, tumor targeting and mitochondrial targeting and offers compounds screening on isolated mitochondria from healthy tissues and tumor cells.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • Faculté de Médecine
  • 8, rue du Général Sarrail
  • 94000 Créteil
  • France

+33 06 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mitologics’s full profile, request a free trial.

Mitologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Mitologics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Agoranov Accelerator/Incubator 000 0000 000000 0

Mitologics Executive Team (3)

Name Title Board
Seat
Contact
Info
Annie Borgne-Sanchez Ph.D Co-Founder, Chief Executive, Chief Scientific Officer & President
Nelly Buron Ph.D Co-Founder & Manager, Research and Development
Mathieu Porceddu Co-Founder & Platform Manager